Alvotech
ALVOW
$0.27
Updated: 24/09/2026, 07:44:19
Market Cap
$2.51B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
LU
Stock valuation chart
One-year closing share-price history for ALVOW
Company Profile
Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.
USD
NASDAQ
CEO: Lisa Graver
Employees: 1,460
Asset Summaries
Latest generated summaries for ALVOW
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for ALVOW.
- Share price
- $0.27
- Market cap
- $2.51B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Lisa Graver
- Employees
- 1,460
- IPO date
- 16/06/2022
- Beta
- 0.192
- Last dividend
- $0.00
- Day range
- $0.27 – $0.27
- 52-week range
- $0.27 – $1.52
- 1-day performance
- -27.03%
- 1-year performance
- 0.00%
- Current drawdown (1Y)
- -82.24%
- CIK
- 0001898416
- CUSIP
- L01800116
- ISIN
- LU2458333858
- Created
- 07/12/2025, 02:02:54
- Last update
- 24/09/2026, 07:44:19
Track Alvotech with an AI analyst
See which prediction-market events move ALVOW, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to ALVOW from your Railway `news_articles` table.
No news found for this symbol.